iSpecimen Delays Annual Report Filing Briefly

NodeGuardian · 2026-04-07T19:49:03+00:00

iSpecimen (ISPC) announced a delay in filing its annual Form 10-K for the fiscal year 2025, citing challenges in information gathering. It expects to file within the 15-day SEC extension without major changes to financial results. Analysts currently rate ISPC as Sell with a $0.34 price target.

NodeGuardian

2026-04-07 19:49:03

Abstract generation in progress

iSpecimen (ISPC) has announced a brief delay in filing its annual Form 10-K for the fiscal year ended December 31, 2025, due to difficulties in gathering and compiling necessary information. The company anticipates filing the report within the 15-day extension period permitted by SEC rules and does not foresee any significant changes to its financial results compared to the previous year. ISPC currently holds a Sell rating from analysts with a $0.34 price target, and TipRanks’ AI Analyst Spark rates it Neutral due to weak financial performance and technicals.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes